Normal development of an organism requires the ability to respond to DNA damage. A particularly deleterious lesion is a DNA double-strand break (DSB). The cellular response to DNA DSBs occurs via an integrated sensing and signaling network that maintains genomic stability. The outcomes of defective DNA DSB repair are related to the developmental stage of an organism, and often show striking tissue specificity. Many human diseases are associated with deficiencies in DNA DSB repair and can be characterized by neuropathology, immune deficiency, growth retardation or predisposition to cancer. This review will focus on the requirements of the DNA DSB response that function to maintain homeostasis during mammalian development.
Introduction
Human syndromes attest to the importance of DNA repair pathways during development. Defects in a variety of DNA repair pathways result in diseases characterized by a range of distinct phenotypes. For example, defects in DNA helicases (for example, Bloom syndrome) can result in dwarfism and increased sister-chromatid exchange, defects in the repair of DNA crosslinks (Fanconi anemia) is associated with diverse congenital abnormalities and bone marrow failure, while defects in the repair of UV damage (for example, xeroderma pigmentosum) can lead to sun-induced skin and eye lesions, and all of these DNA repair syndromes predispose to cancer (van Brabant et al., 2000; Hoeijmakers, 2001; D'Andrea, 2003; Cleaver, 2005) . Human syndromes also result from defective responses to DNA double-strand breaks (DSBs), such as ataxia telangiectasia (AT) and Nijmegen breakage syndrome (NBS) that show striking effects in the nervous and immune systems and exhibit cancer predisposition (McKinnon and Caldecott, 2007) . DNA DSBs are particularly deleterious lesions that can result from a variety of endogenous and exogenous insults.
These human syndromes illustrate the broad spectrum of DNA repair functions that are required for maintaining tissue homeostasis, and underscore the constant requirement for responding to DNA lesions. In the following, we will focus on the DNA DSB response during mammalian development with an emphasis on the tissue-specific requirements for these processes, and the diseases that result from disruption of this pathway.
Repairing DNA DSBs DNA DSBs elicit a profound cellular response that involves activation of cell cycle checkpoints to facilitate DNA repair, or the activation of apoptosis in situations where cell loss can be tolerated via cell replacement. Much of our understanding of these pathways comes from studies using material derived from human syndromes, and more recently mouse genetics has provided a wealth of information, particularly regarding the functional requirements for DNA damage responses in a biological setting (Friedberg and Meira, 2006; Rosenthal and Brown, 2007) .
DNA DSBs are repaired through either of two distinct biochemical pathways, homologous recombination (HR) or non-homologous end joining (NHEJ). Defects in either of these pathways can impact at different developmental stages and in different tissues. A distinguishing feature between the DNA DSB pathways is the requirement of HR for a sister chromatid present in the S/G 2 phase of replicating cells, implying that the repair of DSBs in non-replicating cells occurs via NHEJ.
HR is an error-free process that uses a sister chromatid as template DNA to achieve precise repair (Thacker and Zdzienicka, 2003; West, 2003; Helleday et al., 2007) . Homology-directed repair initially involves an Mre11-Rad50-Nbs1 (MRN)-mediated 5 0 -3 0 resection followed by Rad51-mediated homology search and strand invasion. The Rad51 recombinase functions in concert with a series of other factors including the Rad51 paralogs (Xrcc2, Xrcc3, RAD51L1, RAD51L2, RAD51L3), Rad52 and Rad54 proteins to promote strand invasion and subsequent recombination (West, 2003; Thacker and Zdzienicka, 2004; Wyman et al., 2004; Heyer et al., 2006; Helleday et al., 2007) . Strand invasion and migration involves formation of a structure termed a Holliday Junction, resolution of which via Rad54, Mus81/Emc1 and Rad51C/Xrcc3 occurs following repair synthesis by DNA polymerase to complete the repair process. As would be surmised from the essential importance of HR during embryonic development, studies in the mouse indicate that many of the above factors are required for survival and their inactivation leads to lethality (Friedberg and Meira, 2006) .
In contrast to HR, NHEJ is an error-prone DSB repair mechanism, that involves the DNA-dependent protein kinase (DNA-PK) and the DNA ligase IV (Lig4) complex, which together facilitate re-joining of broken non-compatible DNA ends (Lieber et al., 2003) . The DNA-PK complex contains Ku70 and Ku80 proteins, which recognize the break and mediate recruitment of the DNA-PK catalytic subunit, a protein kinase required for efficient NHEJ (Lees-Miller and Meek, 2003; Bassing and Alt, 2004; Burma and Chen, 2004) . Ligation of the DNA ends occurs via Lig4 in conjunction with its binding partner Xrcc4. An additional factor, Cernunnos/ XLF, has been identified as a binding partner of the Lig4-Xrcc4 complex and appears to be necessary for efficient ligation via NHEJ (Ahnesorg et al., 2006; Buck et al., 2006a) . Subsets of NHEJ may involve other factors such as Artemis (Moshous et al., 2001; Jeggo and O'Neill, 2002) . The extent to which Artemis is required during canonical NHEJ (independent of V(D)J recombination) remains uncertain, as conflicting data on its requirement for end joining have been reported (Rooney et al., 2003; Riballo et al., 2004; Zhang et al., 2004; Wang et al., 2005b) . However, Lig4 and Xrcc4 are essential for NHEJ and embryonic survival (Barnes et al., 1998; Frank et al., 1998; Gao et al., 1998b) , and their interaction is required for efficient end joining as Lig4 is not sufficient to complete repair in the absence of Xrcc4 (Critchlow et al., 1997; Grawunder et al., 1997 Grawunder et al., , 1998a Bassing and Alt, 2004) . While HR is available for repair during late S/G 2 , NHEJ is most prominently activated in G 1 , G 0 and early S phase of the cell cycle (Rothkamm et al., 2003; Thacker and Zdzienicka, 2004) . However, animal studies indicate that there is cooperativity between these pathways during development (Couedel et al., 2004; Mills et al., 2004) .
While NHEJ requires DNA-PK and Lig4, studies suggest that there may be NHEJ repair that utilizes other components, and in some cases can occur without DNA-PK (DiBiase et al., 2000; Perrault et al., 2004) . For instance, DNA ligase III (Lig3) has been implicated as a alternate ligase that may function in NHEJ (Wang et al., 2005a; Windhofer et al., 2007) . In vitro evidence implicating PARP-1 and Xrcc1/Lig3 in NHEJ has also been obtained through end-joining assays (Audebert et al., 2004) . However, the physiologic relevance of such phenomena remains unclear as no substantial compensatory mechanisms appear in Lig4-deficient mice; if Lig3 does compensate in vivo, it does so only partially and is insufficient for normal mammalian development in the absence of Lig4.
Defective NHEJ deficiency and human disease
Disease-causing mutations have been identified in Artemis, Lig4 and Cernunnos-XLF (Moshous et al., 2001; O'Driscoll et al., 2004; Revy et al., 2006) . Radiosensitive severe combined immunodeficiency (RS-SCID) is associated with mutations in Artemis. RS-SCID patients exhibit radiosensitivity and impaired V(D)J recombination associated with decreased or absent circulating T-and B-lymphocytes, often resulting in death within the first year of life due to opportunistic microorganism infection (Moshous et al., 2001) .
Hypomorphic mutations of LIG4 account for LIG4 syndrome, characterized by microcephaly, immunodeficiency, radiosensitivity and developmental delay (O'Driscoll et al., 2001 (O'Driscoll et al., , 2004 . LIG4 syndrome was first identified in a radiosensitive leukemia patient with a missense mutation (R278H), which was subsequently shown to decrease LIG4 adenylation and ligation activity by about 10% (Riballo et al., 1999 (Riballo et al., , 2001 O'Driscoll et al., 2004) . Additional LIG4 syndrome individuals have since been identified and display varying penetrance of the phenotype, due to differing hypomorphic mutations. For instance, an individual carrying the R278H mutation in addition to the N-terminal polymorphisms A3V and T9I presented with microcephaly, pancytopenia and developmental delay (O'Driscoll et al., 2001; Girard et al., 2004) . In vitro studies revealed no residual LIG4 adenylation or ligation activity in that combination of mutations (Girard et al., 2004) . Two siblings who presented with SCID, growth defects and microcephaly were found to harbor compound heterozygous mutations conferring a Q280R substitution on one allele and a K424 frame-shift mutation that resulted in truncation of the C terminus on the other allele (Buck et al., 2006b) . Identification of only hypomorphic mutations in LIG4 syndrome individuals suggests that loss of LIG4 would be incompatible with viability, as partially attenuated activity has a profound developmental defect.
Defective HR and human disease
Because of the central importance of HR to genomic integrity, it is likely that inactivation of important HR repair proteins would not be compatible with viability. In humans bi-allelic hypomorphic mutations of BRCA2 are responsible for some cases of Fanconi anemia (FANC-D1 subgroup; Howlett et al., 2002) , a rare autosomal recessive cancer susceptibility syndrome characterized by congenital abnormalities, progressive bone narrow failure and cellular hypersensitivity to DNA crosslinking agents (D'Andrea and Grompe, 2003; Kennedy and D'Andrea, 2005; Reid et al., 2007) . Defects in the BRCA2 partner-protein PALB2 can also result in FA (Reid et al., 2007; Xia et al., 2007) . Brca2 also functions as an important tumor suppressor as its loss confers susceptibility to breast, ovarian and brain tumors (Hughes-Davies et al., 2003; Offit et al., 2003; Shivji and Venkitaraman, 2004) . Similarly, BRCA1 and NBS1 mutations are also associated with cancer, and it is very likely that mutations in a variety of other HR factors will also predispose to cancer.
Animal models of NHEJ and HR deficiencies
Genetically modified mice have been a critical adjunct to human syndromes for understanding the biology of DNA DSB repair (Table 1) . Currently, most known DSB repair factors have been inactivated in mice (Friedberg and Meira, 2006) . In many cases, disruption of key repair factors lead to embryonic lethality, precluding a full analysis of their function. In those cases conferring early embryonic lethality, conditional gene inactivation is being used to bypass embryonic lethality. These emerging studies will continue to provide important details about the tissue-specific requirements for DNA DSB repair (Jonkers et al., 2001; Frappart et al., 2005 Frappart et al., , 2007 Yan et al., 2006) .
Germline inactivation of components of NHEJ and HR has revealed the importance of individual repair factors, and how they function to maintain genomic stability. Xrcc4
and Lig4 À/À mice are virtually identical in phenotype, and in contrast to the viability of DNA-PK-deficient mice, are embryonic lethal, presumably due to abundant apoptosis of newly postmitotic neurons (Barnes et al., 1998; Frank et al., 1998; Gao et al., 1998b) . Like other NHEJ-deficient models, Xrcc4
À/À and Lig4 À/À embryos also showed impaired V(D)J recombination and embryonic fibroblasts exhibited IR sensitivity and premature senescence (Frank et al., 1998; Gao et al., 1998b) . Ku70
À/À and Ku80
À/À mice, while viable, likewise showed increased apoptosis in post-mitotic neural cells, though to a lesser extent than seen in Xrcc4 À/À and Lig4 À/À embryos (Gu et al., 2000) . Ku70/80 deficiency also imparts radiation sensitivity, proportional dwarfism, impaired V(D)J recombination, abrogation of DSB repair, predisposition to thymic lymphomas and impaired B-cell development (Nussenzweig et al., 1996; Gu et al., 1997; Ouyang et al., 1997) . The DNA-PK phenotype is less severe than that of the Ku-deficient mice, as they exhibit no growth defect or radiation sensitivity despite immunodeficiency (Taccioli et al., 1998; Gao et al., 1998a) . Artemis and (Cheung et al., 2004) Mammary tumor with median latency of 1.6 year Nestin-Cre; Brca2 loxP/loxP (Frappart et al., 2007) Cerebellar development defect, impaired neurogenesis, p53 À/À rescues developmental defects and leads to medulloblastoma ATR Atr À/À (Brown and Baltimore, 2000) Embryonic lethality (before E7.5)
Seckel syndrome
Microcephaly, characteristic facial features, mental retardation, chromosomal instability?
Abbreviations: ATM, ataxia-telangiectasia mutated; NBS, Nijmegen breakage syndrome; RS-SCID, radiosensitive severe combined immunodeficiency.
DNA-PK-deficient mice, while viable, show impaired lymphocyte development and V(D)J recombination, increased cellular sensitivity to ionizing radiation (IR) and spontaneous chromosomal instability (Rooney et al., 2002) . The differential phenotypic severity between NHEJ-deficient mice reflects the relative repair ability in a V(D)J end-joining assay (Gu et al., 2000) . In all cases above, defective NHEJ strongly predisposed to cancer, including lymphoma and brain tumors, when NHEJ defective mice were combined with p53 loss (Guidos et al., 1996; Gao et al., 2000; Lee and McKinnon, 2002; Holcomb et al., 2006) . Germ line inactivation of critical HR components, such as Rad51, Brca2 and Xrcc2 among others results in early embryonic lethality in the mouse as fully functional HR is a critical requirement during development (Friedberg and Meira, 2006) . Notably, in some cases associated loss of p53 can support viability, suggesting that like the examples of NHEJ above, DNA damageinduced apoptosis is often the reason for lethality. When rescue of germline deficiency by p53 occurs, as would be expected for the role of HR in all proliferating tissues, there is a broad spectrum of tumors that arise (Orii et al., 2006) . Accordingly, when HR or NHEJ is selectively inactivated in a tissue-specific manner, tumors reflective of the particular tissue occur, such as breast or brain tumors (Jonkers et al., 2001; Ludwig et al., 2001; Cheung et al., 2004; Yan et al., 2006; Frappart et al., 2007) .
Mice with defective NHEJ have also revealed the importance of this repair pathway in hematopoietic stem cells as a key determinant in their maintenance and indicate that DNA damage accumulation may be a limiting factor for stem cell renewal (Nijnik et al., 2007; Rossi et al., 2007) . Collectively, these mouse models further underscore the critical importance of the DNA DSB repair pathways during mammalian development, and highlight the utility of the mouse as an important biological system for furthering our understanding of DNA repair.
ATM and the DNA DSB response during development
The canonical example of DNA DSB sensitivity in humans is the neurodegenerative syndrome, A-T. This disease is characterized by pronounced cerebellar ataxia and progressive neurodegeneration, ocular telangiectasia, lymphoma, sterility, immunodeficiency and pronounced radiosensitivity (Chun and Gatti, 2004; McKinnon, 2004) . The gene defective in A-T is ataxia-telangiectasia mutated (ATM), a kinase that modulates the activity of a variety of substrates important for engaging the DNA damage response after DNA DSBs. ATM substrates have important functions for regulating cell cycle arrest and apoptosis (Shiloh, 2003 (Shiloh, , 2006 Bakkenist and Kastan, 2004) . Tissue specificity is an important aspect of ATM function, and relates to the wide phenotypic spectrum present in A-T. For instance, some ATMdeficient tissues are extremely radiosensitive such as the intestine or hematopoietic system, while in contrast many ATM-deficient immature neurons are radioresistant (Frappart and McKinnon, 2006) .
The DNA DSB sensitivity of A-T has always prompted a connection to a DNA repair function. However, the direct involvement of ATM in DNA repair has been a contentious issue (McKinnon, 1987) . While the current consensus indicates that ATM functions primarily in signal transduction, there is clearly a direct effect of its loss upon DNA repair, as ATM null cells show chromosomal rearrangements and radiosensitivity. However, this is usually attributed to checkpoint defects resulting in a failure to coordinate DNA repair. Furthermore, in a main system affected in A-T, the nervous system, ATM primarily appears to function in regulating apoptosis to eliminate cells with DNA damage (Herzog et al., 1998) , as also appears to be the case in the immune system Callen et al., 2007) . However, recently ATM-dependent phosphorylation of the NHEJ factor Artemis suggests a direct role in repair of some DSBs (Riballo et al., 2004) , and V(D)J recombination requires a repair function of ATM (Bredemeyer et al., 2006; Callen et al., 2007) , although ATM also has an important apoptotic role in this system (Callen et al., 2007) .
Activation of ATM in response to DNA damage involves autophosphorylation which converts ATM from an inactive dimer into an active monomer (Bakkenist and Kastan, 2003) . ATM autophosphorylation sites have been identified on serine 1981, 1893 and 367 and transfection of A-T cells with cDNAs containing mutations of these sites has shown each site contributes to ATM function (Bakkenist and Kastan, 2003; Kozlov et al., 2006) . However, the in vivo significance of these autophosphorylation events remains unclear. Transgenic mice expressing a S1987A mutated BAC were crossed onto an Atm À/À background and were able to fully correct the phenotype, as growth retardation, genomic instability, lymphocyte development and ATM-dependent phosphorylation of Chk2, SMC1 and p53 were restored to normal in Atm TgS1987A Atm À/À mice (Pellegrini et al., 2006) . Most likely, ATM activation involves multiple post-translational events.
ATM activation involves the MRN complex, as studies of cells deficient in this complex show abrogated ATM autophosphorylation and impaired phosphorylation of its substrates p53, Chk2 and Smc1 and suppression of the ATM-dependent G 2 /M checkpoint (Carson et al., 2003; Uziel et al., 2003; Difilippantonio et al., 2005) . These studies implicate the MRN complex as a primary sensor of DNA damage and place it upstream of ATM activation. A component of this complex, NBS1, is also important for localizing ATM to DNA DSBs after DNA damage (Kitagawa et al., 2004) . MRN-dependent ATM activation at DNA breaks has been reported to require interaction between ATM HEAT repeats and the C-terminal FXF/Y domain of NBS1 (Falck et al., 2005; You et al., 2005) . However, again the in vivo significance of this requires further study as mice engineered to contain a Nbs1 C-terminal truncation were normal for most ATM functions, although some apoptotic defects typical of ATM deficiency were present Stracker et al., 2007) .
Defective DNA DSB responses and A-T-related syndromes
Phenotypic overlap between A-T and diseases caused by Mre11 or NBS1 mutation underpin the physiologic relevance of interactions between ATM and the MRN complex (Figure 1 ). Hypomorphic mutations in Mre11 have been discovered in individuals exhibiting milder characteristics of A-T, resulting in A-T-like disease (ATLD) also characterized by neurodegeneration (Stewart et al., 1999) . Likewise, hypomorphic mutations in NBS1 have been identified as the culprit in NBS (Carney et al., 1998; Varon et al., 1998) . In contrast to A-T, NBS is characterized by microcephaly and is not associated with neurodegeneration or ataxia. However, lymphoma, radiosensitivity and immunodeficiency are common characteristics of NBS (Digweed and Sperling, 2004) .
Defects in ATM and rad3-related (ATR) protein are also involved in aspects of the DNA damage response, and hypomorphic mutations can lead to Seckel syndrome (O'Driscoll et al., 2004; Stiff et al., 2005) . While there is cross talk between ATM and ATR (Jazayeri et al., 2006; Matsuoka et al., 2007; Yoo et al., 2007) , they have separable biochemical roles and complete ATR loss of function, like any of the MRN components, is incompatible with viability (Brown and Baltimore, 2000) . Interestingly, NBS shares more in common with ATR-Seckel syndrome than with A-T, despite clear evidence of ATM-Nbs1 interaction (Figure 1) . As tissuespecific ATR functions are revealed via mouse genetics, it is likely that the signaling interconnections between ATM, ATR and MRN as they relate to human diseases will be uncovered.
Phosphorylation of H2AX at the C terminus Ser 139 is one of the earliest events occurring in response to DNA damage, and can be visualized in cells as the appearance of distinct nuclear foci that mark DNA DSBs (Rogakou et al., 1998) . A major function of g-H2AX is recruitment of DNA damage response factors to the sites of DNA DSBs to enhance the fidelity of DNA repair Fernandez-Capetillo et al., 2004) . While H2AX is not strictly required for development in the mouse, its loss predisposes to genomic instability (Celeste et al., 2002 (Celeste et al., , 2003 . H2AX phosphorylation results in recruitment of mediator of DNA damage checkpoint protein 1 to the DNA break (Goldberg et al., 2003; Lou et al., 2003; Stewart et al., 2003) , via binding to the g-H2AX C terminus, and this interaction is required for signal amplification and effective modulation of downstream ATM signaling (Bekker-Jensen et al., 2005; Stucki et al., 2005; Lou et al., 2006; Stucki and Jackson, 2006) .
The various substrates of ATM and their reported roles in DNA damage signal transduction have been Figure 1 Diseases caused by defective responses to DNA double-strand breaks. Ataxia-telangiectasia mutated (ATM) deficiency results in a pleiotropic phenotype, the most debilitating feature of which is progressive neurodegeneration. MRE11 mutations are associated with A-T-like disease (ATLD), which mimics the neurodegenerative aspect of ataxia telangiectasia (A-T). Though NBS1 acts with MRE11 to regulate ATM activation, NBS1 hypomorphic mutations are associated with microcephaly, not neurodegeneration. The Nijmegen breakage syndrome (NBS) phenotype overlaps with ATM and rad3-related (ATR) deficiency more so than with A-T. Mutation of LIG4 is also associated with microcephaly and resembles NBS and ATR-Seckel syndrome.
thoroughly discussed in many excellent reviews (Kastan and Lim, 2000; Shiloh, 2003 Shiloh, , 2006 Ward and Chen, 2004) . In response to DNA damage, p53 and Chk2 are important ATM substrates that are required to activate checkpoints and apoptosis. Particularly in the nervous system, ATM-dependent apoptosis after DNA damage critically requires activation of p53 and Chk2 (Herzog et al., 1998; Chong et al., 2000; Takai et al., 2002) . ATM indirectly affects p53 stabilization through downregulation of its ubiquitin ligase Mdm2 (Khosravi et al., 1999; Maya et al., 2001) . COP1 is yet another E3 ligase of p53 that ATM phosphorylates, resulting in its degradation and subsequent p53 stabilization (Dornan et al., 2006) . These ATM-dependent modifications serve to modulate ATM substrate function to affect p53-dependent cell cycle arrest or activate apoptosis.
ATM is also implicated in mediating DNA damageinduced chromatin modification. Treatment of primary human fibroblasts with chromatin modifying agents (chloroquine or HDAC inhibitors) induced ATM activation without obvious DNA DSBs, suggesting that direct DNA damage is not the only activator of ATM signaling (Bakkenist and Kastan, 2003) . Identification of ATM-dependent chromatin relaxation via KAP-1 activity following DNA damage has further demonstrated the dependence of DNA repair on alteration of chromatin structure. ATM phosphorylates KAP-1 on Ser 824, and ablation of this site was demonstrated to abolish DSB-induced chromatin relaxation and resulted in cellular hypersensitivity to DSB-inducing agents (Ziv et al., 2006) . Moreover, ATM has also been implicated in regulating ordered chromatin changes after DNA breaks to facilitate DNA repair (Berkovich et al., 2007) .
Modeling the DNA DSB response in the mouse
Atm null mice have provided many insights into the nature of A-T, and they recapitulate many features of the disease, including growth retardation, immunodeficiency, sterility and thymic lymphoma, although no overt neurodegeneration has been found (Barlow et al., 1996; Elson et al., 1996; Herzog et al., 1998) . Human A-T-derived cell lines and mouse Atm-null cells display similar phenotypes including premature senescence, radiation sensitivity, decreased p53 induction and cell cycle checkpoint defects (Barlow et al., 1996; Xu et al., 1998) .
Irradiation studies in the developing Atm-null NS showed that ATM regulates p53-dependent apoptosis of newly post-mitotic neurons, implying that ATM functions as a clearance mechanism of irreparably damaged cells during development. Post-mitotic neurons of the developing CNS and the dorsal root ganglia of postnatal Atm À/À mice were resistant to irradiation-induced apoptosis in comparison to wild-type animals. Consistent with the lack of apoptosis, p53 stabilization was drastically attenuated in the radioresistant Atm À/À tissues and there was a similar lack of apoptosis post-irradiation in p53-null animals (Herzog et al., 1998; Chong et al., 2000; Lee et al., 2001) . Chk2, Puma and Bax deficiencies have also been shown to abrogate DNA DSB-induced apoptosis in the developing nervous system (Chong et al., 2000; Takai et al., 2002; Jeffers et al., 2003) .
The Mre11
ATLD1/ATLD1 mouse model harboring a hypomorphic mutation designed to mimic mutations found in ATLD patients show chromosomal instability and checkpoint defects in primary cell cultures, and female Mre11 ATLD/ATLD failed to produce offspring due to reduced embryonic viability (Theunissen et al., 2003) . Likewise, the nibrin hypomorph Nbs1 DB/DB mouse showed an identical cellular phenotype after DNA damage to that of primary cultures derived from NBS patients including intra-S-phase checkpoint defects, chromosomal instability, and radiosensitivity (Williams et al., 2002) . Additionally, the NBS1 m/m mouse model displayed lymphoma predisposition and infertility, as did the humanized mouse model hNbs1 657D5 (Kang et al., 2002; Difilippantonio et al., 2005) . Further understanding of NBS1 function came with the conditional Nbs1 knockout model, Nbn f6/f6 . Using Nestin-cre to inactivate Nbs1 throughout the nervous system, this mouse demonstrated microcephaly and severe developmental defects of the cerebellum, associated with decreased proliferation of granule cell progenitors and increased apoptosis of inner EGL cell populations (Frappart et al., 2005) .
Rescue of Lig4-mediated apoptosis by Atm-deficiency demonstrated the requirement of ATM-mediated apoptosis during neural development to maintain genomic integrity of cells incorporated into the mature nervous system (Lee et al., 2000; Sekiguchi et al., 2001) . Accordingly, p53 deficiency also rescued Xrcc4/Lig4-mediated apoptosis . Interestingly, Lig4
À/À p53 À/À mice survived into adulthood and developed pro-B-cell lymphomas or medulloblastomas Lee and McKinnon, 2002) , whereas Lig4 À/À Atm À/À animals died perinatally (Lee et al., 2000; Sekiguchi et al., 2001) . These studies suggest that ATM deficiency allows cells carrying a genotoxic level of DSBs to be incorporated into the nervous system, and eventually such neurons succumb to apoptosis or some other form of death resulting in neurodegeneration . Furthermore, these studies suggest a developmental role of ATM and MRN, which is vital in responding to DNA damage.
Perspectives
The DNA DSB response is required for development and maintenance of tissue homeostasis. The DNA damage response is also a barrier to transformation, and if inactive in the face of replication stress, cellular transformation can occur (Bartkova et al., 2005 (Bartkova et al., , 2006 Braig et al., 2005; Di Micco et al., 2006) . Multiple human syndromes result from the mutation of genes required for the response to DNA DSB. In many cases these syndromes feature defective developmental processes, including microcephaly, neurodegeneration, immunodeficiency and growth retardation. Currently, novel human syndromes characterized by immune deficiency, radiosensitivity or other features suggestive of DNA DSB repair are under study to identify their molecular basis. Delineating the underlying molecular defects in these diseases promises to uncover further important details about DNA DSB repair.
As we increase the molecular resolution of the DNA damage response, there will be greater opportunities to manipulate this to improve therapeutic intervention in cancer treatment and ultimately in strategies that will prevent the debilitating consequences of diseases associated with DNA repair deficiency.
